(AGENPARL) - Roma, 13 Agosto 2024 - (AGENPARL) – mar 13 agosto 2024 No images? Click here https://hq_who_departmentofcommunications.cmail19.com/t/d-e-ehihhjl-iitylyihjr-u/
13 August 2024
SITUATION REPORT
COVID-19 epidemiological update – 13 August 2024 [https://www.who.int/publications/m/item/covid-19-epidemiological-update-edition-170]Overview
SARS-CoV-2 PCR percent positivity during the four-week reporting period from 24 June to 21 July 2024, as detected in integrated sentinel surveillance as part of the Global Influenza Surveillance and Response System (GISRS) [https://www.who.int/initiatives/global-influenza-surveillance-and-response-system] and reported to FluNet [https://www.who.int/tools/flunet] increased from 7.4% in the beginning week of the reporting period to 13.0% in the last across eighty-five countries. During this period, an average of 17 358 specimens across 85 countries were tested for SARS-CoV-2 each week.
Globally, during the 28-day period (24 June to 21 July 2024), the number of new cases and deaths increase by 30% and 26% compared to the previous 28-day period (27 May to 23 June 2024), with over one hundred and eighty-six thousand new cases reported across 96 (41%) countries and more than two thousand eight hundred new fatalities reported across 35 (15%) countries, respectively. As of 21 July 2024, over 775 million confirmed cases and more than seven million deaths have been reported globally since the beginning of pandemic.
During the same period, 46 and 35 countries provided data at least once on COVID-19 hospitalizations and admissions to an intensive care unit (ICU), respectively. From the available data, over 23 000 new hospitalizations and more than 600 new ICU admissions were reported. Among the countries reporting these data consistently over the current and past reporting period, there was an overall increase of 11% and 3% in new hospitalizations and new ICU admissions, respectively.
WHO published the latest COVID-19 Vaccination Insights Report [https://www.technet-21.org/en/resources/report/covid-19-vaccination-insights-report-07-june-2024] for quarter one (Jan.-Mar.) 2024. Globally, 9.8 million individuals received a dose of COVID-19 vaccine across 73 reporting Member States (MS). containing 22% of the global population. Among older adults, 4.9 million individuals received a dose across the 60 MS reporting on uptake in this group, corresponding to an uptake rate of 0.42% so far this year.
In this edition, we include:
SARS-CoV-2 test positivity trends at the global and regional levels.The COVID-19 morbidity and mortality update at the global and regional levels.An update on hospitalizations and ICU admissions.An update on the SARS-CoV-2 variants of interest (VOI) and variants under monitoring (VUM).
All COVID-19 Epidemiological and Operational Updates [https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports]
READ MORE [https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox–external-situation-report-35–12-august-2024]
Media contacts:
Trending
- Manifestazioni degli studenti, un intervento del sindaco Luca Salvetti
- Martedì 24 novembre 2026 alle ore 17:00 si riunisce la Commissione Speciale – Livorno: Città per i Giovani
- ASL Lecce: dall’anchilosi alla deambulazione in meno di 24 ore: doppia protesi d’anca con tecnica mini-invasiva all’Ospedale di Casarano
- Martedì 24 novembre 2026 alle ore 9.00 si riunisce la Quinta Commissione Consiliare
- Lunedì 23 novembre 2026 alle ore 14.30 si riunisce la Sesta Commissione Consiliare
- Ricordiamo oggi in Presidenza
- Gli studenti dell’Antonello protagonisti di un doppio appuntamento: lunedì 16 novembre mostra alla GAMeC e presentazione del catalogo a Palazzo dei Leoni
- Agenzia nr. 2119 – Sanità, Borraccino: “in Puglia, una svolta concreta:, firmato l’accordo per oltre 1.100 stabilizzazioni
- Nota stampa Ass. Mosso Piceno – evento del 18 novembre 2026
- Progetto di vita e co-progettazione partecipata: un confronto a partire da altre esperienze